IDIS: PARTNER FOR LIFE

USPTO USPTO 2009 CANCELLED - SECTION 8

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke IDIS: PARTNER FOR LIFE wurde als Wortmarke am 23.11.2009 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 13.09.2011 im Markenregister eingetragen. Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".

Markendetails Letztes Update: 15. Juni 2018

Markenform Wortmarke
Aktenzeichen 77878529
Registernummer 4026669
Anmeldedatum 23. November 2009
Veröffentlichungsdatum 05. Oktober 2010
Eintragungsdatum 13. September 2011

Markeninhaber

Idis House, Churchfield Road, Weybridge
Surrey KT13 8DB
GB

Markenvertreter

Waren und Dienstleistungen

35 Business consultancy services; procurement, namely, purchasing of pharmaceutical products, medicines and drugs for others; business advisory, business management, business information and consultancy services relating to product distribution, operations management services, logistics, reverse logistics, supply chain, and distribution solutions; provision of business networking services; information, advisory and consultancy services, namely, business information and business advisory services in the fields of medical devices and pharmaceuticals and business consultancy services in the field of early access programs and clinical trials
42 Medical and scientific research, namely, managing clinical trials for others not for business purposes; preparation of expert scientific reports in the fields of pharmaceutical research and clinical trials
44 Medical consultancy and advisory services in connection with pharmaceutical preparations and substances, drugs and medicines
45 Regulatory affairs consultancy for the purpose of ensuring compliance with laws and regulations pertaining to pharmaceutical products, medicines and drugs, namely, reviewing and formulating standards and practices, identifying government regulations and policies impacting on pricing and reimbursement and developing strategies to manage them, advising others on regulatory requirements, liaising with, and making presentations to, regulatory authorities, not including providing mail order services featuring specialized information relating to drugs and drug therapy
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1377878529